Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Epertinib is a reversible and selective tyrosine kinase inhibitor of EGFR, HER2, and HER4 (IC50s: 1.48 nM, 7.15 nM, and 2.49 nM). It displays a strong antitumor activity.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 312,500 |
50 mg | 約6-8 週間 | ¥ 406,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | Epertinib is a reversible and selective tyrosine kinase inhibitor of EGFR, HER2, and HER4 (IC50s: 1.48 nM, 7.15 nM, and 2.49 nM). It displays a strong antitumor activity. |
ターゲット&IC50 | EGFR:1.48 nM, HER2:2.49 nM, HER4:7.15 nM |
別名 | S-22611 |
分子量 | 560.02 |
分子式 | C30H27ClFN5O3 |
CAS No. | 908305-13-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Epertinib 908305-13-5 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors HER EGFR S 22611 S-22611 S22611 Inhibitor inhibitor inhibit